Journal List > J Korean Soc Echocardiogr > v.9(1) > 1075373

J Korean Soc Echocardiogr. 2001 Jun;9(1):49-56. Korean.
Published online June 30, 2001.  https://doi.org/10.4250/jkse.2001.9.1.49
Copyright © 2001 Korean Society of Echocardiography
Successful Pregnancy and Delivery in a Patient with a mechanical Valve Using Subcutaneous Injection of Low-Molecular-Weight-Heparin
Soo Jin Kang, Jae Kwan Song, Seung Whan Lee, Jae Hwan Lee, Jun Won Chung, Tae Hoon Oh, Jong Min Song, Duk Hyun Kang and In Sik Lee
Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Division of Obstetrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Abstract

Subcutaneous injection of low-molecular-weight-heparin (LMWH) at home was done for whole gestational period in a 31 year-old female patient with a mechanical prosthetic valve in the mitral position (St. Jude 23 mm). Anti Xa activity and aPTT were regularly monitored once a month, and dosage of LMWH was adjusted to maintain anti Xa activity between 0.6-1.0 IU/ml. Transthoracic echocardiography was performed to check function of a mechanical prosthesis, especially the opening and motion of mechanical bileaflets. Without fetal loss, embolic episode or thrombotic complication, full-term vaginal delivery of a healthy girl could be obtained. LMWH with cautious monitoring of mechanical prosthesis using echocardiography can be a safe, practical and rational option for pregnancy in patients with mechanical prostheses.

Keywords: Prosthetic valve; Pregnancy; Anticoagulation

TOOLS
Similar articles

A Case of Embolism of Left Posterior Tibial Artery after Successful Pregnancy and Delivery in a Patient with a Mechanical Valve Replacement Using Subcutaneous Injection of Low Molecular Weight Heparin

Thromboembolism in pregnancy

Bullous hemorrhagic dermatosis due to enoxaparin use in a bullous pemphigoid patient

Low Molecular Weight Heparin Treatment in Pregnant Women with a Mechanical Heart Valve Prosthesis

Oral Surgery using Low-molecular-weight Heparin in the Anticoagulated Patients